Hollsteen
← Salesforce

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $4.2B · 10-Q 0001108524-15-000014 filed May 22, 2015Equity incl. NCI · Q2 FY2016: $4.5B · 10-Q 0001108524-15-000025 filed Aug 25, 2015Equity incl. NCI · Q3 FY2016: $4.8B · 10-Q 0001108524-15-000034 filed Nov 20, 2015Equity incl. NCI · Q4 FY2016: $5.0B · 10-K 0001108524-16-000053 filed Mar 7, 2016Equity incl. NCI · Q1 FY2017: $5.6B · 10-Q 0001108524-16-000066 filed May 20, 2016Equity incl. NCI · Q2 FY2017: $6.1B · 10-Q 0001108524-16-000085 filed Sep 1, 2016Equity incl. NCI · Q3 FY2017: $6.8B · 10-Q 0001108524-16-000128 filed Nov 21, 2016Equity incl. NCI · Q4 FY2017: $8.2B · 10-K 0001108524-19-000009 filed Mar 8, 2019Equity incl. NCI · Q1 FY2018: $7.9B · 10-Q 0001108524-17-000012 filed May 22, 2017Equity incl. NCI · Q2 FY2018: $9.2B · 10-Q 0001108524-18-000087 filed Nov 28, 2018Equity incl. NCI · Q3 FY2018: $9.7B · 10-Q 0001108524-18-000087 filed Nov 28, 2018Equity incl. NCI · Q4 FY2018: $10.4B · 10-K 0001108524-19-000009 filed Mar 8, 2019Equity incl. NCI · Q1 FY2019: $11.1B · 10-Q 0001108524-18-000035 filed May 31, 2018Equity incl. NCI · Q2 FY2019: $13.5B · 10-Q 0001108524-18-000087 filed Nov 28, 2018Equity incl. NCI · Q3 FY2019: $14.7B · 10-Q 0001108524-18-000087 filed Nov 28, 2018Equity incl. NCI · Q4 FY2019: $15.6B · 10-K 0001108524-19-000009 filed Mar 8, 2019Equity incl. NCI · Q1 FY2020: $16.4B · 10-Q 0001108524-19-000025 filed Jun 5, 2019Equity incl. NCI · Q2 FY2020: $17.2B · 10-Q 0001108524-19-000052 filed Aug 23, 2019Equity incl. NCI · Q3 FY2020: $33.3B · 10-Q 0001108524-19-000076 filed Dec 4, 2019Equity incl. NCI · Q4 FY2020: $33.9B · 10-K 0001108524-20-000014 filed Mar 5, 2020Equity incl. NCI · Q1 FY2021: $34.6B · 10-Q 0001108524-22-000007 filed Jun 1, 2020Equity incl. NCI · Q2 FY2021: $38.4B · 10-Q 0001108524-20-000041 filed Aug 28, 2020Equity incl. NCI · Q3 FY2021: $40.3B · 10-Q 0001108524-20-000047 filed Dec 4, 2020Equity incl. NCI · Q4 FY2021: $41.5B · 10-K 0001108524-21-000014 filed Mar 17, 2021Equity incl. NCI · Q1 FY2022: $42.6B · 10-Q 0001108524-21-000030 filed Jun 2, 2021Equity incl. NCI · Q2 FY2022: $55.5B · 10-Q 0001108524-21-000047 filed Aug 27, 2021Equity incl. NCI · Q3 FY2022: $57.1B · 10-Q 0001108524-21-000055 filed Dec 2, 2021Equity incl. NCI · Q4 FY2022: $58.1B · 10-K 0001108524-22-000013 filed Mar 11, 2022Equity incl. NCI · Q1 FY2023: $58.9B · 10-Q 0001108524-22-000022 filed Jun 1, 2022Equity incl. NCI · Q2 FY2023: $60.1B · 10-Q 0001108524-22-000041 filed Aug 25, 2022Equity incl. NCI · Q3 FY2023: $59.4B · 10-Q 0001108524-22-000060 filed Dec 1, 2022Equity incl. NCI · Q4 FY2023: $58.4B · 10-K 0001108524-23-000011 filed Mar 8, 2023Equity incl. NCI · Q1 FY2024: $57.4B · 10-Q 0001108524-23-000023 filed Jun 1, 2023Equity incl. NCI · Q2 FY2024: $58.1B · 10-Q 0001108524-23-000040 filed Aug 31, 2023Equity incl. NCI · Q3 FY2024: $58.1B · 10-Q 0001108524-23-000048 filed Nov 30, 2023Equity incl. NCI · Q4 FY2024: $59.6B · 10-K 0001108524-24-000005 filed Mar 6, 2024Equity incl. NCI · Q1 FY2025: $59.7B · 10-Q 0001108524-24-000009 filed May 30, 2024Equity incl. NCI · Q2 FY2025: $57.6B · 10-Q 0001108524-24-000022 filed Aug 29, 2024Equity incl. NCI · Q3 FY2025: $58.5B · 10-Q 0001108524-24-000034 filed Dec 4, 2024Equity incl. NCI · Q4 FY2025: $61.2B · 10-K 0001108524-25-000006 filed Mar 5, 2025Equity incl. NCI · Q1 FY2026: $60.7B · 10-Q 0001108524-25-000030 filed May 29, 2025Equity incl. NCI · Q2 FY2026: $61.3B · 10-Q 0001108524-25-000088 filed Sep 4, 2025Equity incl. NCI · Q3 FY2026: $60.0B · 10-Q 0001108524-25-000238 filed Dec 4, 2025Equity incl. NCI · Q4 FY2026: $59.1B · 10-K 0001108524-26-000060 filed Mar 2, 2026Equity incl. NCI · Q1 FY2027: $34.2B · 10-Q 0001108524-26-000127 filed May 28, 2026Equity incl. NCI · Q2 FY2027: $38.4B · 10-Q 0001108524-26-000190 filed Aug 27, 20265.038.44.261.3Q1 FY2016Q2 FY2027
Q4 FY2016
5.0$B
All values (46)
PeriodValue ($B)Status
Q2 FY202738.4reported
Q1 FY202734.2reported
Q4 FY202659.1reported
Q3 FY202660.0reported
Q2 FY202661.3reported
Q1 FY202660.7reported
Q4 FY202561.2reported
Q3 FY202558.5reported
Q2 FY202557.6reported
Q1 FY202559.7reported
Q4 FY202459.6reported
Q3 FY202458.1reported
Q2 FY202458.1reported
Q1 FY202457.4reported
Q4 FY202358.4reported
Q3 FY202359.4reported
Q2 FY202360.1reported
Q1 FY202358.9reported
Q4 FY202258.1reported
Q3 FY202257.1reported
Q2 FY202255.5reported
Q1 FY202242.6reported
Q4 FY202141.5reported
Q3 FY202140.3reported
Q2 FY202138.4reported
Q1 FY202134.6reported
Q4 FY202033.9reported
Q3 FY202033.3reported
Q2 FY202017.2reported
Q1 FY202016.4reported
Q4 FY201915.6reported
Q3 FY201914.7reported
Q2 FY201913.5reported
Q1 FY201911.1reported
Q4 FY201810.4reported
Q3 FY20189.7reported
Q2 FY20189.2reported
Q1 FY20187.9reported
Q4 FY20178.2reported
Q3 FY20176.8reported
Q2 FY20176.1reported
Q1 FY20175.6reported
Q4 FY20165.0reported
Q3 FY20164.7reported
Q2 FY20164.5reported
Q1 FY20164.2reported

CSV with all sources · Technical ID: equity_total

More metrics for Salesforce
Sources & calculation
Value
$5.0B
Period
Q4 FY2016, ended Jan 31, 2016 · as of Jan 31, 2016 (balance as of date, not a sum)
Source
10-K, filed Mar 7, 2016 · 0001108524-16-000053
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$5.0BMar 7, 201610-K 0001108524-16-000053reported · confidence 1. · current